Mar 10, 2022 | Healthcare, Pharma/Bio
Nearly 23% of Europe’s MRI equipment is more than 10 years old. In 2021, developed economies replaced 35 to 50% of MRI scanners. Ideally replacement happens at 8 to 10 years, but some geographies extend the life cycle to 14 years. Frost & Sullivan, Global...
Aug 13, 2021 | Advanced Materials, Biotechnology, Pharma/Bio
‘Demand for personal exoskeletons also rose during pandemic as people with physical disabilities sought ways to continue to receive therapy and personal assistance in their homes. The exoskeleton market is expected to grow from $576.6 million in 2020 to reach...
Jul 30, 2021 | COVID-19, Healthcare, Pharma/Bio
“The global market for vaccine technologies totalled $40.1 billion in 2019. The market should grow from $42.6 billion in 2020 to $57.8 billion by 2025, at a compound annual growth rate (CAGR) of 6.3% during the 2020-2025 forecast period”. (BCC, Global...
Feb 4, 2021 | Health, Pharma/Bio
The Vitamins, Minerals And Supplements Market will continue to grow despite the economic downturn, due to strong associations in supporting specific areas of wellness, particularly ones trending in the time of COVID-19. Mintel Vitamins, Minerals and Supplements...
Oct 2, 2020 | Consumer, COVID-19, Pharma/Bio, Technology
An increased adoption of contactless surfaces post pandemic will drive the home automation and security markets. Systems encompassing voice activation technology will become increasingly popular among consumers. Sales of smart home devices will see a 30%...
Jun 29, 2020 | COVID-19, EMOST, Pharma/Bio
“The COVID-19 pandemic has brought to the fore several gaps in our understanding of health, wellness, and prevention. It has the potential to disrupt the standard norms of prevention and treatment. Even though world organizations thought they had conquered the...
Mar 12, 2020 | Connected Health, Health, Healthcare, Medtech, Medtech, Pharma/Bio
“The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.” BCC Research – ROI in Pharmaceutical R&D: How to Halt the Decline BCC...
Jan 24, 2020 | Healthcare, Pharma/Bio
“At present, neurodegenerative diseases represent one of the main causes of death in the industrialized economy. Overall characterized by a loss of neurons in particular regions of the nervous system, the subsequent decline in cognitive and motor function that...
